277 related articles for article (PubMed ID: 8118381)
1. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
[TBL] [Abstract][Full Text] [Related]
2. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
[TBL] [Abstract][Full Text] [Related]
4. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
Grant DM; Mörike K; Eichelbaum M; Meyer UA
J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
[TBL] [Abstract][Full Text] [Related]
5. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
[TBL] [Abstract][Full Text] [Related]
6. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
[TBL] [Abstract][Full Text] [Related]
7. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.
Ho CC; Lin TH; Lai YS; Chung JG; Levy GN; Weber WW
Drug Metab Dispos; 1996 Feb; 24(2):137-41. PubMed ID: 8742223
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.
Trinidad A; Kirlin WG; Ogolla F; Andrews AF; Yerokun T; Ferguson RJ; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):238-47. PubMed ID: 2568903
[TBL] [Abstract][Full Text] [Related]
10. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
[TBL] [Abstract][Full Text] [Related]
11. Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients.
Kirlin WG; Ogolla F; Andrews AF; Trinidad A; Ferguson RJ; Yerokun T; Mpezo M; Hein DW
Cancer Res; 1991 Jan; 51(2):549-55. PubMed ID: 1985773
[TBL] [Abstract][Full Text] [Related]
12. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
[TBL] [Abstract][Full Text] [Related]
13. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
Reeves PT; Kinnear BF; Minchin RF; Ilett KF
Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
[TBL] [Abstract][Full Text] [Related]
14. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
15. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
Martell KJ; Levy GN; Weber WW
Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells.
Swaminathan S; Reznikoff CA
Cancer Res; 1992 Jun; 52(12):3286-94. PubMed ID: 1375866
[TBL] [Abstract][Full Text] [Related]
17. Caffeine as a potential indicator for acetylator status.
Rankin RB; Hudson SA; Fell AF
J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
[TBL] [Abstract][Full Text] [Related]
18. Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells.
Kloth MT; Gee RL; Messing EM; Swaminathan S
Carcinogenesis; 1994 Dec; 15(12):2781-7. PubMed ID: 8001235
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
20. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
